AAAAAA
Results:
1-23
|
Results: 23
Authors:
METMAN LV
DELDOTTO P
BLANCHET PJ
VANDENMUNCKHOF P
CHASE TN
Citation: Lv. Metman et al., BLOCKADE OF GLUTAMATERGIC TRANSMISSION AS TREATMENT FOR DYSKINESIAS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE, Amino acids, 14(1-3), 1998, pp. 75-82
Authors:
METMAN LV
BLANCHET PJ
VANDENMUNCKHOF P
DELDOTTO P
NATTE R
CHASE TN
Citation: Lv. Metman et al., A TRIAL OF DEXTROMETHORPHAN IN PARKINSONIAN-PATIENTS WITH MOTOR RESPONSE COMPLICATIONS, Movement disorders, 13(3), 1998, pp. 414-417
Authors:
VANDENMUNCKHOF P
LENZ FA
CHASE TN
METMAN LV
Citation: P. Vandenmunckhof et al., SQUARE-WAVE ACTION DYSTONIA IN PARKINSONS-DISEASE, Movement disorders, 13(2), 1998, pp. 354-356
Authors:
METMAN LV
VANDENMUNCKHOF P
KLAASSEN AAG
BLANCHET P
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., SUPRATHRESHOLD LEVODOPA DOSES, DYSKINESIAS, AND DISABILITY IN ADVANCED PARKINSONS-DISEASE - REPLY, Neurology, 51(2), 1998, pp. 649-650
Authors:
METMAN LV
DELDOTTO P
NATTE R
VANDENMUNCKHOF P
CHASE TN
Citation: Lv. Metman et al., DEXTROMETHORPHAN IMPROVES LEVODOPA-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE, Neurology, 51(1), 1998, pp. 203-206
Authors:
METMAN LV
DELDOTTO P
VANDENMUNCKHOF P
FANG J
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., AMANTADINE AS TREATMENT FOR DYSKINESIAS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE, Neurology, 50(5), 1998, pp. 1323-1326
Authors:
METMAN LV
LOCATELLI ER
BRAVI D
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., APOMORPHINE RESPONSES IN PARKINSONS-DISEASE AND THE PATHOGENESIS OF MOTOR COMPLICATIONS - REPLY, Neurology, 50(2), 1998, pp. 574-574
Authors:
LENZ FA
SUAREZ JI
METMAN LV
REICH SG
KARP BI
HALLETT M
ROWLAND LH
DOUGHERTY PM
Citation: Fa. Lenz et al., PALLIDAL ACTIVITY DURING DYSTONIA - SOMATOSENSORY REORGANIZATION AND CHANGES WITH SEVERITY, Journal of Neurology, Neurosurgery and Psychiatry, 65(5), 1998, pp. 767-770
Authors:
SUAREZ JI
METMAN LV
REICH SG
DOUGHERTY PM
HALLETT M
LENZ FA
Citation: Ji. Suarez et al., PALLIDOTOMY FOR HEMIBALLISMUS - EFFICACY AND CHARACTERISTICS OF NEURONAL-ACTIVITY, Annals of neurology, 42(5), 1997, pp. 807-811
Authors:
METMAN LV
DELDOTTO P
VANDENMUNCKHOF P
FANG J
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., AMANTADINE PALLIATES MOTOR RESPONSE COMPLICATIONS IN PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 66-66
Authors:
BLANCHET PJ
PAPA SM
METMAN LV
MOURADIAN MM
CHASE TN
Citation: Pj. Blanchet et al., MODULATION OF LEVODOPA-INDUCED MOTOR RESPONSE COMPLICATIONS BY NMDA ANTAGONISTS IN PARKINSONS-DISEASE, Neuroscience and biobehavioral reviews, 21(4), 1997, pp. 447-453
Authors:
METMAN LV
VANDENMUNCKHOF P
KLAASSEN AAG
BLANCHET P
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., EFFECTS OF SUPRATHRESHOLD LEVODOPA DOSES ON DYSKINESIAS IN ADVANCED PARKINSONS-DISEASE, Neurology, 49(3), 1997, pp. 711-713
Authors:
METMAN LV
BLANCHET PJ
NATTE R
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., THE EFFECT OF DEXTROMETHORPHAN ON LEVODOPA ASSOCIATED DYSKINESIAS IN PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 5137-5137
Authors:
METMAN LV
LOCATELLI ER
BRAVI D
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., APOMORPHINE RESPONSES IN PARKINSONS-DISEASE AND THE PATHOGENESIS OF MOTOR COMPLICATIONS, Neurology, 48(2), 1997, pp. 369-372
Authors:
BLANCHET PJ
METMAN LV
MOURADIAN MM
CHASE TN
Citation: Pj. Blanchet et al., ACUTE PHARMACOLOGICAL BLOCKADE OF DYSKINESIAS IN PARKINSONS-DISEASE, Movement disorders, 11(5), 1996, pp. 580-581
Authors:
METMAN LV
BLANCHET PJ
DEJONG D
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., EFFECT OF THE PUTATIVE DOPAMINE D-1 AGONIST AND D-2 ANTAGONIST FCE-23884 ON PARKINSONS-DISEASE, Movement disorders, 11(3), 1996, pp. 257-260
Authors:
TEDESCHI G
BERTOLINO A
LUNDBOM N
BONAVITA S
PATRONAS NJ
DUYN JH
METMAN LV
CHASE TN
DICHIRO G
Citation: G. Tedeschi et al., CORTICAL AND SUBCORTICAL CHEMICAL PATHOLOGY IN ALZHEIMERS-DISEASE AS ASSESSED BY MULTISLICE PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING, Neurology, 47(3), 1996, pp. 696-704
Authors:
CHASE TN
METMAN LV
BRAVI D
ROBERTS JW
SIBLEY DR
MOURADIAN MM
Citation: Tn. Chase et al., DOPAMINE-RECEPTOR SUBTYPE-SELECTIVE AGONISTS IN THE TREATMENT OF PARKINSONS-DISEASE, Clinical neuropharmacology, 18, 1995, pp. 207-215
Authors:
METMAN LV
SETHY VH
ROBERTS JR
BRAVI D
HOFF JI
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., MOTOR EFFECTS OF THE PARTIAL DOPAMINE AGONIST (-)-3-(3-HYDROXYPHENYL)-N-N-PROPYLPIPERIDINE (PRECLAMOL) IN PARKINSONS-DISEASE, Movement disorders, 9(5), 1994, pp. 577-581
Authors:
METMAN LV
HOFF J
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., FLUCTUATIONS IN PLASMA LEVODOPA AND MOTOR-RESPONSES WITH LIQUID AND TABLET LEVODOPA CARBIDOPA, Movement disorders, 9(4), 1994, pp. 463-465
Authors:
METMAN LV
SETHY VH
ROBERTS JR
BRAVI D
HOFF JI
MOURADIAN MM
CHASE TN
Citation: Lv. Metman et al., MOTOR EFFECTS OF THE PARTIAL DOPAMINE AGONIST (-)-3-PPP (PRECLAMOL) IN PARKINSONS-DISEASE, Neurology, 44(4), 1994, pp. 10000244-10000244
Authors:
SOHN YH
METMAN LV
BRAVI D
LINFANTE I
AOTSUKA A
MOURADIAN MM
CHASE TN
Citation: Yh. Sohn et al., LEVODOPA PEAK RESPONSE-TIME REFLECTS SEVERITY OF DOPAMINE NEURON LOSSIN PARKINSONS-DISEASE, Neurology, 44(4), 1994, pp. 755-757
Authors:
ROBERTS JW
CORALOCATELLI G
BRAVI D
METMAN LV
MOURADIAN MM
CHASE TN
Citation: Jw. Roberts et al., CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITOR RO 40-7592 PROLONGS DURATION OF ACTION OF LEVODOPA CARBIDOPA IN PARKINSONIAN-PATIENTS, Neurology, 43(4), 1993, pp. 332-332
Risultati:
1-23
|